HPM Partners »

Lisata Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $31k 12k 2.52
2025-06-30 $32k 12k 2.65

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corp Stock (MSFT)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Alphabet Stock (GOOGL)
Alphabet Stock (GOOG)
Ishares Tr Etf (QUAL)
Meta Platforms Stock (META)

View all positions for HPM Partners

Top funds holding Lisata Therapeutics

Vanguard Group
Renaissance Technologies
BML Capital Management
Geode Capital Management
BlackRock
Ground Swell Capital
Dimensional Fund Advisors
State Street Corporation
HPM Partners
XTX Topco
Northern Trust
HighTower Advisors
Royal Bank of Canada
Founders Capital Management
Tower Research Capital

View all funds holding Lisata Therapeutics